Exelon
Links shared publicly online about this topic
Sun Pharma Announces Launch Of Generic Exelon(R) In US
medicalnewstoday.com — “Sun Pharma announced launch of generic Exelon®, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.” View full resource at medicalnewstoday.com
Most Recently Shared on July 7, 2010 at 1:07 pm By:
MNT Parkinson's News Health News
Sun Pharma Announces Launch Of Generic Exelon(R) In US http://mnt.to/3FMX #parkinsons
Exelon Says Its 17 Reactors Are Safe - NYTimes.com
nytimes.com — “Exelon, the largest operator of nuclear plants in the United States, says it can handle emergencies not anticipated when the reactors were designed.” View full resource at nytimes.com
Most Recently Shared on March 25, 2011 at 5:23 am By:
NYTimes Science Science Enthusiast
Exelon, Largest U.S. Reactor Owner, Seeks to Reassure http://nyti.ms/gmplnH
Verizon, Exelon to Record Health-Care Charge - WSJ.com
online.wsj.com — “Verizon is expected to take a one-time hit of $970 million to account for new overhaul” View full resource at online.wsj.com
Most Recently Shared on April 2, 2010 at 4:05 am By:
Verizon, Exelon to Record Charge http://on.wsj.com/bsZ0n0
Novartis files suit against Watson over generic Exelon
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.” View full resource at news-medical.net
Most Recently Shared on November 11, 2011 at 5:17 am By:
Parkinson's Disease: Novartis files suit against Watson over generic Exelon: Watson Pharmaceuticals, Inc. today ... http://t.co/ldd6pUdi
Potential Exelon Reactor in Texas Draws Foes - NYTimes.com
nytimes.com — “Citing problems with the chosen site, a Texas group objects to Exelon--™s plan to build a reactor sometime in the future.” View full resource at nytimes.com
Most Recently Shared on December 25, 2010 at 3:14 am By:
NYTimes Science Science Enthusiast
Early Bid for a Reactor Site Draws Opposition in Texas http://nyti.ms/hnESvl
Exelon Corp. To Buy Constellation Energy For 7.9 Billion Dollars | ThirdAge
thirdage.com — “Exelon Corp., the U.S. energy giant, said Thursday it had agreed to merge with Constellation Energy in a $7.9 billion deal.” View full resource at thirdage.com
Most Recently Shared on April 28, 2011 at 10:00 pm By:
Exelon Corp. To Buy Constellation Energy For 7.9 Billion Dollars http://bit.ly/lA5j3l
Exelon | Drug safety information | Monitoring more than 280 patients | MediGuard
mediguard.org — “Exelon | Drug safety information | Monitoring more than 280 patients | MediGuard” View full resource at mediguard.org
Most Recently Shared on March 21, 2011 at 12:17 pm By:
MediGuard.org Health Organization
Over 110856888 #exelon users sharing experiences on MediGuard.org: http://tinyurl.com/6kp6x7c
Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon capsules - FiercePharma
fiercepharma.com — “Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon® capsules Princeton, New Jersey; July 1, 2010 -- Sandoz today announced the introduction of rivastigmine... Read more...” View full resource at fiercepharma.com
Most Recently Shared on July 1, 2010 at 7:46 pm By:
Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon® capsules. http://bit.ly/aux2sj
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Prometax (rivastigmine) - Drugs.com MedNews
drugs.com — “The European Medicines Agency has been formally notified by Novartis Europharm Ltd of its decision to withdraw its applications for an extension of the therapeu” View full resource at drugs.com
Most Recently Shared on March 16, 2012 at 2:02 pm By:
Drugs and Devices OW OW Health
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Promet... http://t.co/eDJZGt8w #drug
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Prometax (Rivastigmine) - Drugs.com MedNews
drugs.com — “From Targeted News Service (March 15, 2012) The European Union s Medicines Agency issued the following news release The European Medicines Agency has been forma” View full resource at drugs.com
Most Recently Shared on March 16, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
Novartis Europharm Ltd Withdraws its Applications for an Extension of the Indication for Exelon and Promet... http://t.co/LfAgJZpP #drug
NHS Easier access to Alzheimer's drugs donepezil (Aricept), galantamine (Reminyl), memantine (Ebixa) and rivastigmine (Exelon)
webmd.boots.com — “Thousands of people with Alzheimer's disease who have been denied medical treatment could soon be given access to life-changing drugs on the NHS.” View full resource at webmd.boots.com
Most Recently Shared on October 7, 2010 at 6:46 am By:
Easier access to Alzheimer’s drugs. http://goo.gl/PtC7
Anti-Delirium Drug May Harm Critically Ill Patients - Drugs.com MedNews
drugs.com — “The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates. W” View full resource at drugs.com
Most Recently Shared on November 5, 2010 at 3:17 am By:
Anti-Delirium Drug May Harm Critically Ill Patients - http://bit.ly/9lnPiq
Anti-Delirium Drug May Harm Critically Ill Patients - Drugs.com MedNews
drugs.com — “The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates. W” View full resource at drugs.com
Most Recently Shared on November 5, 2010 at 12:05 am By:
Drugs and Devices OW OW Health
Anti-Delirium Drug May Harm Critically Ill Patients: THURSDAY, Nov. 4 -- The anti-delirium drug rivastigmi... http://bit.ly/bvPjQH #drug
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet
thelancet.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...” View full resource at thelancet.com
Most Recently Shared on November 10, 2010 at 7:29 pm By:
PalMD Doctor, Internist, and Physician
Study of Exelon in hosp. delirium stopped due to excess mortality http://bit.ly/adSLBf http://www.thelancet.com/
Anti-Delirium Drug May Harm Critically Ill Patients
health.yahoo.net — “THURSDAY, Nov. 4 (HealthDay News) -- The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates.” View full resource at health.yahoo.net
Most Recently Shared on November 5, 2010 at 11:29 am By:
Jane Anderson Healthy Eating Advisor
Anti-Delirium Drug May Harm Critically Ill Patients http://bit.ly/9fQFd5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Parkinson's News
The latest parkinson's disease news published daily. Articles from research centers, universities and prestigious journals.
-
NYTimes Science
Science, Enviornment, Space and Cosmos News From NYTimes.com/Science
-
WSJ Health
Health news coverage from the Wall Street Journal
Advertisement
